Brief: Lisata Therapeutics Receives Paediatric Investigation Plan Waiver From European Medicines Agency
20/05/2024 14:22
May 20 (Reuters) - Lisata Therapeutics Inc LSTA.O :
* LISATA THERAPEUTICS RECEIVES PAEDIATRIC INVESTIGATION PLAN
WAIVER FROM THE EUROPEAN MEDICINES AGENCY FOR CERTEPETIDE IN
PANCREATIC CANCER
* LISATA THERAPEUTICS INC - WAIVER CONFIRMS THAT PAEDIATRIC
STUDIES OF CERTEPETIDE IN PANCREATIC CANCER ARE NOT NEEDED
Source text for Eikon: ID:nGNX8cwg5b
Further company coverage: LSTA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lisata Therapeutics
See all newsBrief: Lisata Therapeutics - Amends Merger Offer Price To $4 Per Share Plus CVR
Brief: Lisata Therapeutics Enters Into Definitive Agreement To Be Acquired By Kuva Labs, Inc.
U.S. STOCKS ON THE MOVE-Oklo, AMD, Lam Research
U.S. STOCKS ON THE MOVE-Aligos, Intel, Travelers Companies
Lisata jumps as Kuva Labs strikes acquisition deal